Cargando…

Immune response in SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Aguilar-Shea, Antonio Luis, Mayo, Cristina Gallardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652106/ https://www.ncbi.nlm.nih.gov/pubmed/33209851 http://dx.doi.org/10.4103/jfmpc.jfmpc_1539_20

Ejemplares similares

Reinfection by SARS-CoV-2: The first one in a family reported in Spain
por: Aguilar-Shea, Antonio L., et al.
Publicado: (2021)

Reinfection by SARS-CoV-2: The first one in a family reported in Spain
por: Aguilar-Shea, Antonio L., et al.
Publicado: (2021)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy
por: Finsterer, Josef
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 infection in children with febrile neutropenia
por: Flores, Victoria, et al.
Publicado: (2020)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

False positives in SARS-CoV-2 disease()
por: Pardo-Lledias, Javier, et al.
Publicado: (2021)

Research during the SARS-CoV-2 pandemic()
por: Muñoz de Nova, José Luis, et al.
Publicado: (2021)

Can the host immune response against SARS-CoV2 also cause an anticancer effect?
por: Kahraman, Seda, et al.
Publicado: (2021)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
por: Vijayaraghavan, Radha, et al.
Publicado: (2023)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

Response to ‘Multimorbidity and SARS-CoV-2 infection in UK biobank’
por: Sur Roy, Abhipsha, et al.
Publicado: (2020)

Response to “Emphysematous cholecystitis in suspected SARS-CoV-2 infection”()
por: Gómez Sánchez, Javier, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in the Vatican City State
por: Ralli, Massimo, et al.
Publicado: (2021)

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia
por: Carrabba, Maria, et al.
Publicado: (2022)

Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hej5oi62f3tdaonfkmcl535r54